CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:LARP4-mediated hypertranslation drives T cell dysfunction in tumors.
LARP4-mediated hypertranslation drives T cell dysfunction in tumors.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
过继性T细胞疗法具有治疗实体瘤的潜力,但长期疗效受到肿瘤微环境中功能适应性下降和持久性差的限制。本研究表明,瘤内T细胞经历翻译组重塑,在获得功能障碍特征的同时转变为高翻译状态。RNA结合蛋白LARP4是一种翻译调控因子,通过选择性增强耗竭T细胞中核编码氧化磷酸化(OXPHOS)mRNA的翻译,驱动高翻译和功能障碍,破坏OXPHOS亚基平衡并导致线粒体功能障碍。在肿瘤特异性CD8+ T细胞中敲除Larp4可减少高翻译,恢复线粒体功能,减轻耗竭并增强效应持久性,从而增强抗肿瘤反应。此外,在CAR-T 细胞中敲低LARP4可防止终末耗竭并改善对血液肿瘤和实体瘤的应答。本研究强调翻译失调是肿瘤中T细胞功能障碍的决定因素。
Adoptive T cell therapies have therapeutic potential for treating solid tumors, but long-term efficacy is limited by reduced functional fitness and poor persistence within the tumor microenvironment.
Here we show that intratumoral T cells undergo translatome remodeling, transitioning into a hypertranslational state as they acquire dysfunctional traits. The RNA-binding protein LARP4 is a translation regulator that drives hypertranslation and dysfunction by selectively enhancing the translation of nuclear-encoded oxidative phosphorylation (OXPHOS) mRNAs in exhausted T cells, disrupting OXPHOS subunit balance and causing mitochondrial dysfunction.
Knockout of Larp4 in tumor-specific CD8 + T cells reduces hypertranslation, restores mitochondrial function, mitigates exhaustion and enhances effector persistence, resulting in enhanced anti-tumor responses.
Additionally, LARP4 knockdown in chimeric antigen receptor T cells prevents terminal exhaustion and improves the response to liquid and solid tumors.
This study highlights translation dysregulation as a determinant of T cell dysfunction in tumors.
MEMBER ACCOUNT
登录成功会直接打开下一页。